Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Adam Mead and Peter McHugh, who were awarded the title of full professor in the recent Recognition of Distinction.

This is a huge achievement and reflects the excellence of their research achievements and also their commitment to teaching and ‘good citizenship’ within our Institute and beyond.

Prof Adam Mead, Professor of Haematology, leads a team investigating how the normal haematopoietic stem/progenitor hierarchy is disrupted during the development of myeloid malignancies. The overarching aim of his research group is to improve the management of myeloproliferative neoplasms (MPN), chronic myeloid leukaemia (CML) and related conditions through better characterisation and therapeutic targeting of malignant stem and progenitor cell populations. Adam is a Consultant Haematologist and an MRC Senior Clinical Fellow at the Radcliffe Department of Medicine.

Prof Peter McHugh, Professor of Molecular Oncology, researches DNA damage and repair mechanisms. His research group is interested in how these processes take place in normal, healthy cells, but also how they are used by cancer cells to resist treatment and repair their DNA. He is particularly interested in inter-strand crosslinks and a specific family of DNA repair nucleases. Peter is a Professor in the Department of Oncology.

Many congratulations as well to Dr Anindita Roy, now Associate Professor of Paediatrics Haematology (Department of Paediatrics); and Dr David Sims, now a University Research Lecturer (MRC WIMM Centre for Computational Biology and Radcliffe Department of Medicine).

Anindita Roy

Similar stories

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.

2022 RDM Graduate Prize Winners

This year's RDM winners are Edward Jenkins, Antje Rottner, and Akshay Shah.

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing

The biotechnology company builds upon research conducted by Professor Jim Hughes and Prof. James Davies at the MRC Weatherall Institute of Molecular Medicine, and combines 3D genome technology and machine learning to decode the dark matter of the human genome.

KJ Patel appointed new Chief Scientist of CRUK

Alongside his new role at Cancer Research UK, Prof. Patel will continue as the Director of both the MRC Weatherall Institute for Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU).

September is Childhood Cancer Awareness Month

September is Childhood Cancer Awareness Month, where our Childhood Leukaemia research group have taken action to help raise awareness for this cause.